Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis

ClinicalTrials.gov ID: NCT03451045

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03451045. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2 multicenter, double-blind, randomized, placebo-controlled study assessing the efficacy and safety of lenabasum for the treatment of cystic fibrosis in patients 12 years of age or older. Approximately 415 subjects will be enrolled in this study at about 100 sites in North America, and Europe. The planned duration of treatment with study drug is 28 weeks. Study drug will be lenabasum 20 mg BID, lenabasum 5 mg BID, and placebo in a 2:1:2 ratio.

Study identification

NCT ID
NCT03451045
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Corbus Pharmaceuticals Inc.
Industry
Enrollment
447 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 22, 2017 (Actual)
Primary completion
Jun 17, 2020 (Actual)
Completion
Jun 17, 2020 (Actual)
Last update posted
Jan 18, 2023

2017 – 2020

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
33
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
Miller Children's Hospital Long Beach California 90806 —
National Jewish Health Denver Colorado 80206 —
University of Miami Miami Florida 33136 —
Central Florida Pulmonary Group, PA Orlando Florida 32803 —
USF Center for Advance Lung Disease Tampa Florida 33606 —
Emory Children's Center Atlanta Georgia 30322 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
The Cystic Fibrosis Institute Glenview Illinois 60025 —
Johns Hopkins University Baltimore Maryland 21205 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Boston Children's Hospital Boston Massachusetts 02115 —
Dartmouth-Hitchcock Medical Center (main location) Lebanon New Hampshire 03756 —
Dartmouth-Hitchcock Manchester (satellite site) Manchester New Hampshire 03104 —
Atlantic Health Children's Hospital Morristown New Jersey 07960 —
Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
New York Medical College Hawthorne New York 10532 —
North Shore LIJ Health System New Hyde Park New York 11040 —
Mount Sinai Beth Israel New York New York 10003 —
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Oregon Health and Science University Portland Oregon 97239 —
Milton S. Hershey Medical Center / Penn State College of Medicine Hershey Pennsylvania 17033 —
Drexel University College of Medicine Philadelphia Pennsylvania 19102 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Medical University of South Carolina Charleston South Carolina 29425 —
Sanford Children's Specialty Clinic Sioux Falls South Dakota 57105 —
UT Southwestern Medical Center Dallas Texas 75390 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Texas Children's Hospital Houston Texas 77030 —
The University of Texas Health Science Center at Tyler Tyler Texas 75708 —
University of Utah Salt Lake City Utah 84132 —
University Hospital and UW Health Clinics Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03451045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2023 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.